Joshua Riezman - 08 Aug 2025 Form 4 Insider Report for MEI Pharma, Inc. (MEIP)

Role
Director
Signature
/s/ Justin J. File, as Attorney-in-fact for the Reporting Person
Issuer symbol
MEIP
Transactions as of
08 Aug 2025
Transactions value $
$0
Form type
4
Filing time
20 Aug 2025, 17:56:34 UTC
Previous filing
20 Aug 2025
Next filing
18 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Riezman Joshua Director 9920 PACIFIC HEIGHTS BLVD., SUITE 150, SAN DIEGO /s/ Justin J. File, as Attorney-in-fact for the Reporting Person 20 Aug 2025 0002082518

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MEIP Stock Option (Right to Buy) Award $0 +10K $0.00 10K 08 Aug 2025 Common Stock 10K $5.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Such option shall vest and become exercisable in 36 equal monthly installments, with the first installment vesting on the one-month anniversary of the date of grant, subject to continued service through the applicable vesting date.